Syros Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
SYRS
CUSIP
87184Q206
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 8 483 k $12.4 k
2024 Q4 51 5.22 M $1.20 M
2024 Q3 74 19.2 M $41.4 M
2024 Q2 76 20.4 M $105 M
2024 Q1 82 21.0 M $112 M
2023 Q4 65 19.5 M $149 M
2023 Q3 50 12.1 M $47.9 M
2023 Q2 56 10.6 M $33.5 M
2023 Q1 60 10.3 M $27.5 M
2022 Q4 59 10.6 M $38.0 M
2022 Q3 54 8.45 M $54.4 M